Trust In CDC Has Now Fallen To 47%, KFF Poll Says. Here Are The Risks
A January 2026 KFF poll shows only 47% of Americans trust the CDC, down from 63% in September 2023. Trust has eroded across the political spectrum, with Democrats at 55%, Republicans at 43%, and independents at 46%. The decline began during the COVID‑19 pandemic and has persisted despite leadership changes, including the 2025 appointment of Robert F. Kennedy Jr. as HHS secretary. Analysts warn that waning confidence threatens effective disease‑control, fuels misinformation, and could impair future outbreak responses.
The BIG Summit Meets at the Intersection of Patient Advocacy and Venture Investment
At the BIO Investor Growth (BIG) Summit, IBD Ventures’ associate director Nicole Schwerbrock discussed how venture philanthropy and patient advocacy are reshaping investment in inflammatory bowel disease (IBD) research. She explained that patient‑driven funding models complement traditional venture capital by...
Public Health Preparedness: Improved Coordination Needed for HHS’s Emergency Preparedness Programs
The U.S. Department of Health and Human Services (HHS) awarded nearly $900 million in FY 2024 through its Public Health Emergency Preparedness (PHEP) and Hospital Preparedness Program (HPP) to state and local jurisdictions. GAO found that the two HHS agencies managing these...
CMS Renews AHCH’s Deemed Status as Hospice Accreditor
The U.S. Centers for Medicare & Medicaid Services (CMS) has renewed the Accreditation Commission for Health Care’s (ACH C) deemed status as an accreditor for both hospice providers and critical‑access hospitals. The six‑year renewal, effective through 2031, confirms that ACHC’s standards...
Institutional Familiarity & Product-Specific Knowledge Keys for Health Systems Selecting Managed IT Services Partners, KLAS Finds
A February 2026 KLAS Research analysis of 19 health‑system IT outsourcing decisions found pre‑existing vendor relationships to be the top driver of managed‑IT services selection, eclipsing cost, expertise and credibility. The study identified five firms—CereCore, HCTec, Nordic, Impact Advisors and CTG—as...
Will AI Eventually De-Skill Doctors? The Evidence Is Trickling In
New research indicates that routine AI assistance can erode physicians' clinical instincts, a phenomenon termed de‑skilling. A 2025 Lancet study found endoscopists' adenoma detection rates dropped from 29% to 22% after regular AI use, suggesting skill decay in non‑AI procedures....
Northwell Temporarily Closes Beds, Cuts Jobs at Long Island Rehabilitation Facility
Northwell Health announced the temporary closure of a 30‑bed unit at its Orzac Center for Rehabilitation in Valley Stream, resulting in the layoff of more than 30 union workers, including licensed practical nurses, certified nursing assistants and physical therapists. The...
Partner Therapeutics Reports P-II (eNRGy) Post-Hoc Results on Zenocutuzumab for NRG1+ NSCLC
Partner Therapeutics presented post‑hoc data from its Phase II eNRGy study of zenocutuzumab (Bizengri) in 27 patients with advanced NRG1‑positive non‑small cell lung cancer who received at least three doses beyond radiographic progression. Eight patients stayed on therapy for six months...
STAT+: Novo Nordisk’s Next-Gen Obesity Drug Stumbles in Comparison Study
Novo Nordisk’s next‑generation obesity drug CagriSema failed to demonstrate non‑inferiority to Eli Lilly’s tirzepatide in the 84‑week REDEFINE 4 study, achieving 20.2% weight loss versus 23.6% for tirzepatide. The open‑label trial showed the two treatments were not statistically equivalent. Following the announcement,...
Operating a New Standard for Life-Saving Pharmaceutical Logistics
Pharmaceutical logistics faces $38 billion annual waste due to fragmented temperature‑controlled networks and customs delays. Frontier Scientific Solutions, based in Wilmington and Shannon, has built a purpose‑built, cGMP‑grade infrastructure that integrates storage, monitoring and direct airside access. By consolidating routes, the...
Transforming Epilepsy Care: How Innovative Implantable Neurotechnology Offers New Hope
PRECISIS GmbH’s EASEE® epicranial neurostimulation system offers a minimally invasive alternative for drug‑resistant focal epilepsy. The implant, positioned under the scalp atop the skull, delivers targeted electrical pulses without opening the skull, achieving a median 68% seizure reduction over two...
J&J Reports Long-Term QUASAR Data for Tremfya in Ulcerative Colitis
Johnson & Johnson released long‑term QUASAR extension data for Tremfya (guselkumab) in ulcerative colitis, showing sustained efficacy through week 140. Clinical remission was achieved by 80.8% of patients, with 78.6% attaining histo‑endoscopic improvement and 53.6% reaching endoscopic remission. Approximately 89% of...
Podcast: Which Pharma and Medtech Companies Came Out on Top in 2025 Revenues?
The 2025 earnings season highlighted a clear hierarchy among healthcare giants, with Eli Lilly and AstraZeneca leading pharma revenue growth and Medtronic and Edwards Lifesciences topping medtech sales. The podcast hosted by Robert Barrie and Ross Law breaks down the financial results, noting...
STAT+: Pharma Lobbyists Focus on a Surprising New Target: The FDA
Health Secretary Robert F. Kennedy Jr. has pledged to purge industry influence from the FDA, yet the Trump administration’s injection of political priorities has reshaped the agency’s operating environment. Under the current administration, discussions that once were deemed off‑limits between...
How Handheld Ultrasound Systems Improve Point-of-Care Imaging
Handheld ultrasound systems are reshaping point‑of‑care imaging by delivering portable, real‑time diagnostic capability directly at the bedside. Their lightweight design allows clinicians to move quickly between patients, cutting imaging wait times and supporting rapid decision‑making in emergencies. The technology also...
Pulselight Platform Now Available to NHS via £10bn Fortrus Framework
Pulselight has become an authorised partner on the £10 bn Fortrus Digital Enablement Framework, giving NHS trusts a fast, compliant route to acquire its advanced data‑analytics platform. The framework, created by the Countess of Chester Hospital NHS Foundation Trust, streamlines procurement...
AI Bolsters Breast Radiologists’ Cancer Detection Rate, Real World Study Finds
A multi‑center real‑world study of over 100,000 breast imaging exams found that adding iCAD’s AI tool to digital breast tomosynthesis increased cancer detection rates without raising recall rates. Detection of invasive cancers rose 26%, while overall cancer detection per 1,000...
Noted North Carolina Private Radiology Practice Experiences Data Breach
Triad Radiology Associates, a 50‑year‑old North Carolina imaging practice, disclosed a data breach affecting roughly 11,000 patients. The intrusion, detected in February, likely occurred between late July and September and exposed names, addresses, Social Security numbers and bank account details....
Vanda Pharmaceuticals Reports the US FDA’s Approval of Bysanti (Milsaperidone) for Acute Bipolar I Disorder & Schizophrenia
Vanda Pharmaceuticals announced that the U.S. FDA has approved Bysanti (milsaperidone), an active metabolite of iloperidone, as a first‑line therapy for acute manic or mixed episodes in bipolar I disorder and for schizophrenia. The approval is based on demonstrated bioequivalence...
Beyond Generative AI: Why Healthcare’s Next Leap Depends on Agentic Systems That Can Actually Do the Work
Healthcare’s administrative crisis stems from fragmented, manual workflows rather than mere documentation. While generative AI has streamlined drafting tasks, it fails to automate end‑to‑end processes like prior authorizations, eligibility checks, and denial management. Agentic AI systems, capable of pulling data...
Sickle Cell Gene Therapies Casgevy and Lyfgenia Still Lacking Traction 2 Years In
In February 2024 Vertex and CRISPR Therapeutics launched Casgevy, and bluebird bio (now Genetix Biotherapeutics) launched Lyfgenia as the first FDA‑approved gene therapies for sickle cell disease. Two years later, uptake remains modest—only 64 patients received Casgevy and just over 100...
Beyond Rezdiffra: The 4 Most Promising MASH Pipelines in Play
Madrigal’s Rezdiffra became the first approved therapy for metabolic dysfunction‑associated steatohepatitis (MASH), generating $817 million in revenue within six quarters and prompting a wave of big‑pharma acquisitions focused on FGF21 analogs. In 2025, GSK, Roche and Novo Nordisk spent nearly $10 billion acquiring...
‘Sweet Surprise by Aster’ Raises Awareness on Hidden Sugar as UAE’s Sugar Tax Takes Effect
The UAE introduced a tiered sugar tax on January 1 2026, targeting beverages by sugar content per 100 ml. In response, Aster Clinics UAE opened the Aster Diabetes 360 Care Clinic in Al Qusais and launched the “Sweet Surprise by Aster” campaign, featuring a vending machine...
'It Was Like Buying Groceries' - Woman Calls for Tighter Weight-Loss Jabs Checks
Emma Dyer bought weight‑loss injections online for £115, bypassing any medical assessment, and suffered a severe health collapse within days. Her experience reflects a wider surge, with an estimated 1.6 million UK adults using GLP‑1 drugs such as Mounjaro and Wegovy,...
Vir Biotechnology Inc (VIR) Q4 2025 Earnings Call Transcript
CVRx reported fourth‑quarter 2025 revenue of $16 million, a modest 4% rise, while gross margin improved to 86% driven by higher selling prices and manufacturing efficiencies. The company added 13% more active implanting centers, reaching 252, and expanded U.S. sales territories...
GeneDx Holdings Corp (WGS) Q4 2025 Earnings Call Transcript
GeneDx Holdings reported Q3 2025 revenue of $116.7 million, a 52% year‑over‑year increase, driven by a 66% jump in exome and genome revenue to $98.9 million and 25,702 tests performed. Adjusted gross margin rose to 74% as higher reimbursement rates and a...
Summit Therapeutics Inc (SMMT) Q4 2025 Earnings Call Transcript
Summit Therapeutics reported a strong cash position of $713 million with no debt at the end of 2025, while GAAP operating expenses fell to $225 million despite a rise in non‑GAAP R&D spend. The FDA accepted the Biologics License Application for ivonesumab...
Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Transcript
Myriad Genetics reported Q4 2025 revenue of $209.8 million, essentially flat year‑over‑year but above its pre‑announced range, while test volume rose 2% to 382,000. Strong double‑digit growth was seen in MyRisk hereditary cancer (14% affected, 11% unaffected), Prolaris prostate cancer (12%...
Tarsus Pharmaceuticals Inc (TARS) Q4 2025 Earnings Call Transcript
Tarsus Pharmaceuticals reported record 2025 net product sales of $451.4 million, driven by XDEMVY adoption, and issued its first full‑year 2026 guidance forecasting $670‑$700 million, implying over 50% revenue growth. The company highlighted a 44% gross‑to‑net discount, a robust DTC campaign that...
Addus Homecare Corp (ADUS) Q4 2025 Earnings Call Transcript
Humana reported adjusted 2025 EPS of $17.14, matching guidance and surpassing the $16.25 estimate. The company added roughly 1 million Medicare Advantage members, a 20% increase, while improving retention by over 500 basis points. New sales were dominated by high‑value channels,...
Immunitybio Inc (IBRX) Q4 2025 Earnings Call Transcript
AbbVie reported a record $61.2 billion in net revenue for 2025, an 8.6% increase that beat guidance despite a $16 billion HUMIRA erosion. Adjusted EPS reached $10, $0.54 above the midpoint, while SKYRIZI and RINVOQ together generated $7.4 billion in Q4, delivering double‑digit...
Hims & Hers Health Inc (HIMS) Q4 2025 Earnings Call Transcript
Hims & Hers Health reported Q4 2025 revenue of $171 million, a 46% year‑over‑year increase, and full‑year revenue of $588 million, up 51% and ahead of guidance. Gross margin rose to 85% in the quarter and 83% for the year, while operating...
HealthStream Inc (HSTM) Q4 2025 Earnings Call Transcript
HealthStream reported record Q3 2025 results, posting $76.5 million revenue, a 4.6% year‑over‑year increase, and new highs in operating income, net income and adjusted EBITDA. Subscription revenue rose 5.7% driven by strong CredentialStream, ShiftWizard and Competency Suite growth, while legacy product...
This AI Can Improve Your Peer Review — and Make It More Polite
Researchers at Stanford introduced the Review Feedback Agent, an AI coach that leverages five large language models to improve peer‑review comments. In a test on roughly 20,000 reviews for the 2025 ICLR conference, the system flagged vague, unprofessional, or fact‑incorrect...
Axsome Therapeutics Inc (AXSM) Q4 2025 Earnings Call Transcript
Axsome Therapeutics reported a 66% revenue surge to $639 million in 2025, driven by strong growth in Auvelity, Sunosi and the newly launched Cymbravo. Net loss narrowed to $183 million, a 35% improvement year‑over‑year, while cash rose to $323 million. The company secured...
Trends and Patterns of Medical Stimulant Use by US Adults
Recent analyses reveal a steady rise in medical stimulant prescriptions among U.S. adults, with a 30% increase between 2013 and 2022. The expansion of telehealth, especially after COVID‑19, contributed to roughly 40% of new adult ADHD initiations, while FDA alerts...
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Call Transcript
BioMarin Pharmaceutical raised its fiscal 2025 total revenue guidance, now starting at $3.15 billion, and reaffirmed Voxzogo revenue between $900 million and $935 million. The company lifted non‑GAAP operating margin guidance to 26‑27% and lifted diluted EPS guidance to $3.50‑$3.60. A $221 million IPR&D...
Octave Specialty Group Inc (OSG) Q4 2025 Earnings Call Transcript
Oscar Health reported a 28% revenue jump to $11.7 billion for 2025, driven by strong membership growth that lifted year‑end enrollment to 2 million and a total of 3.4 million members by February 2026. The company posted a $443 million net loss, largely from...
AI Tools Can Design Genomes. Will They Upend How Life Evolves?
Artificial‑intelligence tools are now capable of designing genes that function in mammalian cells and have even generated a fully synthetic virus, marking a watershed for generative biology. In his new book, Adrian Woolfson outlines how computational models could evolve into...
First-of-a-Kind Stem Cell Therapies Set for Approval in Japan
Japan’s health ministry is set to grant conditional approval to two first‑of‑a‑kind regenerative medicines – Amchepry for Parkinson’s disease and ReHeart for severe heart failure – after tiny phase I/II trials involving seven and eight patients respectively. Both drugs are derived...
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Transcript
SI‑BONE reported record Q4 2025 revenue of $56.3 million, a 15% year‑over‑year increase, and full‑year sales of $200.9 million, up 20.2%. The company posted its first positive adjusted EBITDA ($5.1 million) and generated free cash flow for the quarter, narrowing the net loss...
Large Language Model Reads Radiologists' Notes to Flag Patients for Follow-Up Imaging
Researchers at Parkland Health created an AI‑powered tool that leverages a pre‑trained large language model to read radiologists' free‑text notes and automatically flag patients needing follow‑up imaging. In testing on 130,000 studies, the model identified 97% of imaging recommendations and...
Neuro-Symbolic AI and the Quest for Trusted Intelligence in Professional Sectors
Neuro‑symbolic AI merges deep‑learning intuition with symbolic logic, addressing the strict reasoning demands of legal, medical, and financial workflows. By 2026 hybrid models verify outputs against hard‑coded rules, delivering trustworthy, compliant results. The approach powers automated legal discovery, precision medicine...
Mississippi Healthcare System Shuts Down Clinics After Ransomware Attack
The University of Mississippi Medical Center (UMMC) suffered a ransomware attack on February 19 that crippled its Epic EHR, IT network, and phone systems, forcing the shutdown of nearly 30 clinics and a shift to paper‑based documentation. Vice Chancellor LouAnn...
Louise Milligan Leads FOUR CORNERS Surgeon Scandal
Four Corners aired "Scarred", exposing a Melbourne gynaecologist accused of performing unnecessary laparoscopic surgeries on women in their twenties. Pathology reports often found little or no endometriosis, yet organs and tissue were removed, compromising fertility and causing chronic pain. The...
AI Is Changing Nursing Education and Raising New Graduate Expectations
AI is reshaping nursing education, prompting curricula to incorporate AI documentation, simulation, and analytics tools. Hospitals face acute staffing gaps, with 25% of new nurses leaving within a year and a projected shortage of 63,700 RNs by 2030. Universities are...
Combating Antibacterial Resistant Diseases with Lasers
Researchers led by Texas A&M’s Dr. Vanderlei Bagnato are developing laser‑based, light‑activated therapies to combat antibiotic‑resistant infections. The method uses a safe photoreactive compound that, when activated by infrared light, disrupts bacterial defenses, allowing conventional antibiotics to work at normal...
Adolescent Depression Subtypes Show Distinct Brain Dynamics
A new Nature Communications study reveals two neurobiologically distinct subtypes of adolescent major depressive disorder by analyzing information dynamics in sensory‑association cortices. One subtype shows heightened feedforward signaling, correlating with sensory hypersensitivity and anxiety, while the other exhibits reduced feedback...
Engineered Nanoparticles Could Deliver Better Targeted Cancer Treatment to Lymph Nodes
Scientists at McGill University and the Goodman Cancer Institute have engineered nanoparticles that deliver an existing immunotherapy directly to metastatic lymph nodes. The nanocomplex senses a molecule abundant in cancer‑laden nodes, activating the drug only at the disease site while...
Safe Ultrasound Opens Brain Barrier via Tight Junctions
Researchers have detailed how focused ultrasound safely and reversibly opens the blood‑brain barrier by transiently reorganizing tight‑junction proteins. The study shows that pulsed ultrasound creates a brief paracellular window that permits therapeutic agents to reach brain tissue without causing inflammation...